Decoy Therapeutics Inc. (formerly Salarius Pharmaceuticals) is a pre-clinical stage biotechnology company developing peptide conjugate therapeutics via its proprietary IMP3ACT platform, which uses AI/ML and high-speed synthesis. The company focuses on infectious diseases and oncology, advancing Designable Multi-Antivirals (D-MAVs) targeting respiratory viruses, and retains legacy small molecule assets SP-3164 (protein degrader) and seclidemstat (SP-2577, protein inhibitor) from Salarius.
expected 2026-12-23
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001193125-26-134897 | EDGAR | 62K words |
| 2025-03-21 | 2024-12-31 | 0001615219-25-000037 | EDGAR | 52K words |
| 2024-03-22 | 2023-12-31 | 0001615219-24-000025 | EDGAR | 47K words |
| 2023-03-27 | 2022-12-31 | 0001615219-23-000030 | EDGAR | 53K words |
| 2022-03-25 | 2021-12-31 | 0001615219-22-000028 | EDGAR | 53K words |
| 2021-03-18 | 2020-12-31 | 0001615219-21-000026 | EDGAR | 51K words |
| 2020-03-23 | 2019-12-31 | 0001615219-20-000014 | EDGAR | 50K words |
| 2019-03-06 | 2018-12-31 | 0001615219-19-000008 | EDGAR | 60K words |
| 2018-03-07 | 2017-12-31 | 0001615219-18-000018 | EDGAR | 76K words |
| 2017-03-08 | 2016-12-31 | 0001615219-17-000021 | EDGAR | 75K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-12 | 2026-06-30 | 0001193125-26-346852 | EDGAR | 15K words |
| 2025-11-14 | 2025-09-30 | 0001615219-25-000164 | EDGAR | 33K words |
| 2025-08-12 | 2025-06-30 | 0001615219-25-000096 | EDGAR | 18K words |
| 2025-05-14 | 2025-03-31 | 0001615219-25-000048 | EDGAR | 16K words |
| 2024-11-14 | 2024-09-30 | 0001615219-24-000089 | EDGAR | 13K words |
| 2024-08-09 | 2024-06-30 | 0001615219-24-000071 | EDGAR | 14K words |
| 2024-05-13 | 2024-03-31 | 0001615219-24-000040 | EDGAR | 12K words |
| 2023-11-09 | 2023-09-30 | 0001615219-23-000071 | EDGAR | 17K words |
| 2023-08-10 | 2023-06-30 | 0001615219-23-000061 | EDGAR | 15K words |
| 2023-05-11 | 2023-03-31 | 0001615219-23-000038 | EDGAR | 11K words |
| 2022-11-10 | 2022-09-30 | 0001615219-22-000150 | EDGAR | 15K words |
| 2022-08-05 | 2022-06-30 | 0001615219-22-000124 | EDGAR | 14K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-23 | 0001615219-26-000019 | EDGAR | 1K words |
| 2026-09-15 | 0001615219-26-000016 | EDGAR | 1K words |
| 2026-07-15 | 0001193125-26-304949 | EDGAR | 1K words |
| 2026-04-02 | 0001193125-26-139145 | EDGAR | 1K words |
| 2026-03-05 | 0001193125-26-092748 | EDGAR | 1K words |
| 2026-02-25 | 0001193125-26-068813 | EDGAR | 1K words |
| 2026-01-08 | 0001615219-26-000013 | EDGAR | 1K words |
| 2026-01-02 | 0001615219-26-000005 | EDGAR | 1K words |
| 2026-01-02 | 0001615219-26-000003 | EDGAR | 1K words |
| 2025-12-19 | 0001615219-25-000197 | EDGAR | 1K words |
272 total filings indexed. 240 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001615219 |
| Ticker | DCOY |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.decoytx.com |
| Listed | 2015-01-29 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/DCOY (~200 tokens, structured JSON with cryptographic provenance)